These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 355984
1. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)]. Lang JM, Bigel P, Oberling F, Mayer S. Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984 [Abstract] [Full Text] [Related]
2. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)]. Lang JM, Bigel P, Oberling F, Mayer S. Sem Hop; 1978; 54(37-40):1155-8. PubMed ID: 217096 [Abstract] [Full Text] [Related]
3. Persisting lymphocyte deficiences during remission in Hodgkin's disease. Björkholm M, Holm G, Mellstedt H. Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164 [Abstract] [Full Text] [Related]
4. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)]. Lang JM, Bigel P, Giron C, Faradji A, Oberling F, Mayer S. Nouv Presse Med; 1979 Nov 12; 8(44):3629-32. PubMed ID: 316521 [Abstract] [Full Text] [Related]
5. Quantitative study of T and B lymphocytes in Hodgkin's disease. Bensa JC, Micouin C, Schaerer R, Sotto JJ, Hollard D. Biomedicine; 1977 Apr 12; 26(2):137-44. PubMed ID: 326312 [Abstract] [Full Text] [Related]
6. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease. Land JM, Litwin J, Bigel P, Oberling F, Mayer S. Acta Haematol Pol; 1977 Apr 12; 8(2):131-4. PubMed ID: 329629 [Abstract] [Full Text] [Related]
7. Levamisole in the treatment of Hodgkin's disease. Berényi E, Kávai M, Szabolcsi M, Szegedi G. Acta Med Acad Sci Hung; 1979 Apr 12; 36(2):177-85. PubMed ID: 317549 [Abstract] [Full Text] [Related]
8. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease]. Pluzańska A. Acta Haematol Pol; 1978 Apr 12; 9(1):37-44. PubMed ID: 307325 [Abstract] [Full Text] [Related]
9. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes. Matchett KM, Huang AT, Kremer WB. J Clin Invest; 1973 Aug 12; 52(8):1908-17. PubMed ID: 4541673 [Abstract] [Full Text] [Related]
10. Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission. Gobbi M, Fiacchini M, Tomasini I, Ruggero D, Lauria F, Tura S. Boll Ist Sieroter Milan; 1977 Mar 31; 56(2):144-51. PubMed ID: 326273 [Abstract] [Full Text] [Related]
11. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease. Bodolay E, Berényi E, Sonkoly I, Szegedi G. Acta Med Hung; 1984 Mar 31; 41(2-3):113-9. PubMed ID: 6611543 [Abstract] [Full Text] [Related]
14. [Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy]. Nagel GA, Pietra CD, Hartmann D, Rosenthal M, Albrecht R, Obrist R, Obrecht P. Schweiz Med Wochenschr; 1979 Jan 13; 109(2):45-51. PubMed ID: 311514 [Abstract] [Full Text] [Related]
15. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease. Levo Y, Rotter V, Ramot B. Biomedicine; 1975 Jun 30; 23(6):198-200. PubMed ID: 1082352 [Abstract] [Full Text] [Related]
17. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. Fuks Z, Strober S, Kaplan HS. N Engl J Med; 1976 Dec 02; 295(23):1273-8. PubMed ID: 185517 [Abstract] [Full Text] [Related]